NCT02442700View on ClinicalTrials.gov

Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
HIVDyslipidemia
Interventions
DRUG

pitavastatin

Treatment A = administration pitavastatin for 12 weeks

DRUG

placebo

Treatment B = administration placebo for 12 weeks

All Listed Sponsors
lead

Ramathibodi Hospital

OTHER

NCT02442700 - Effects of Pitavastatin on Lipid Profiles in HIV-infected Patients With Dyslipidemia and Receiving Atazanavir/Ritonavir | Biotech Hunter | Biotech Hunter